Research Alliance Corp III S-4/A, filed Oct 30, 2026
Research Alliance Corp III (RACC)
Research Alliance Corporation III seeks shareholder approval at its November 24, 2026 meeting for a business combination with Oak Hill Bio, which has a $160,000,000 base equity value, plus a $55,000,000 PIPE financing. AI summary
S-4/A
2026-10-30
View Original
Added on
October 30, 2026